Diabetes Dialogue: Breaking Down Barriers to the Early Use of GLP-1 RAs in Primary Care

Did you know therapeutic inertia is a key driver of uncontrolled type 2 diabetes?   Credit available for this activity expires: 9/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996617?ecd=bdc_podcast_libsyn_mscpedu